Want to see TSE:AVNT full AI Analyst Report?
Top Page
Avant Brands
(TSX:AVNT)
Select Model
Select Model
Rating:46Neutral
Price Target:
C$0.52
▼(-13.50% Downside)
Action:Reiterated
Date:10/21/26
The score is held down primarily by weak profitability (large net loss and thin gross margin) and bearish technical signals (price below major moving averages with negative MACD). Positive operating and free cash flow plus modest leverage provide some support, but a negative P/E and the lack of dividend data limit valuation confidence.
Positive Factors
Positive cash generation
Positive operating and free cash flow provides internal funding for ongoing operations and reduces reliance on external capital. Although earnings remain negative, current cash conversion offers some resilience and supports the company’s ability to maintain its regulated cannabis activities.
Negative Factors
Contracting revenue
Recent revenue contraction indicates that the company has not yet sustained its earlier expansion trajectory. A shrinking top line can reduce operating leverage, weaken investment capacity, and make it harder for Avant Brands to spread fixed costs across a larger regulated cannabis revenue base.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive cash generation
Positive operating and free cash flow provides internal funding for ongoing operations and reduces reliance on external capital. Although earnings remain negative, current cash conversion offers some resilience and supports the company’s ability to maintain its regulated cannabis activities.
Read all positive factors
Avant Brands (AVNT) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$7.61M
Dividend YieldN/A
Average Volume (3M)10.66K
Price to Earnings (P/E)―
Beta (1Y)-0.16
Revenue Growth-15.88%
EPS Growth59.93%
CountryCA
Employees180
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.79
Shares Outstanding15,372,549
10 Day Avg. Volume13,777
30 Day Avg. Volume10,662
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.36
Price to Sales (P/S)0.25
P/FCF Ratio1.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Avant Brands Business Overview & Revenue Model
Company Description
Avant Brands Inc. operates in Canada, focusing on the cultivation, production, and commercialization of high-quality cannabis products. The company provides both medical and recreational cannabis options, marketed under distinct brands including B...
How the Company Makes Money
Avant Brands makes money primarily by selling cannabis products into regulated channels, generating revenue when its products are purchased by wholesalers, distributors, pharmacies/medical channels, or other authorized buyers depending on the juri...
Avant Brands Earnings Call Summary
Earnings Call Date:Apr 15, 2024
(Q1-2024)
| % Change Since: |
Next Earnings Date:Mar 04, 2027
Earnings Call Sentiment Positive
Avant Brands reported strong financial performance with record revenue and growth, positive cash flow, and international market expansion despite competitive challenges in the Canadian market.Positive Updates
Record Revenue and Growth
Avant Brands exceeded guidance with gross revenue of $8.9 million and net revenue increased by 15% year-over-year to a record $8.1 million. Gross margin reached a record $4.7 million with a healthy 58% margin overall.
Negative Updates
Competitive Canadian Market
The Canadian recreational market, especially in Ontario, remains highly competitive, impacting domestic performance.
Read all updates
Q1-2024 Updates
Positive
Negative
Record Revenue and Growth
Avant Brands exceeded guidance with gross revenue of $8.9 million and net revenue increased by 15% year-over-year to a record $8.1 million. Gross margin reached a record $4.7 million with a healthy 58% margin overall.
Read all positive updates
Company Guidance
During the Avant Brands Q1 2024 earnings call, the company disclosed a robust financial performance, surpassing their guidance with gross revenue reaching $8.9 million, against an anticipated $8.2 to $8.8 million. Net revenue climbed by 15% year-over-year, hitting a record $8.1 million. The gross margin was at a healthy 58%, with Canadian recreational sales at 63% and exports achieving an impressive 74% margin. The firm generated a record positive cash flow of $3.8 million and reported an adjusted EBITDA of the same amount, reflecting a 47% margin. Avant also announced a private placement to secure up to $3.89 million to bolster working capital, with a strategic investor contributing a lead order of $600,000. Additionally, the company’s export channel expanded significantly with five new agreements, solidifying its presence in international markets and offsetting domestic challenges.Avant Brands Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
58
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.33M | 35.90M | 35.80M | 26.34M | 20.15M | 9.50M |
| Gross Profit | 3.17M | -3.65M | -1.68M | 12.43M | 3.91M | 664.00K |
| EBITDA | -13.11M | -13.82M | -19.45M | 4.53M | -1.89M | -9.65M |
| Net Income | -9.72M | -9.88M | -22.55M | -5.07M | -7.54M | -11.23M |
Balance Sheet | ||||||
| Total Assets | 45.16M | 49.24M | 59.47M | 82.55M | 67.03M | 50.57M |
| Cash, Cash Equivalents and Short-Term Investments | 1.11M | 1.49M | 1.74M | 794.00K | 6.78M | 14.49M |
| Total Debt | 12.14M | 15.31M | 17.01M | 18.70M | 3.01M | 623.00K |
| Total Liabilities | 21.88M | 24.44M | 26.62M | 33.22M | 18.79M | 2.70M |
| Stockholders Equity | 21.73M | 24.80M | 32.85M | 49.33M | 43.92M | 47.87M |
Cash Flow | ||||||
| Free Cash Flow | 2.66M | 5.71M | 401.00K | 1.85M | -4.90M | -6.22M |
| Operating Cash Flow | 4.75M | 5.75M | 507.00K | 5.41M | -3.46M | -5.62M |
| Investing Cash Flow | -290.00K | 211.00K | -78.00K | -7.03M | -3.10M | -1.65M |
| Financing Cash Flow | -4.34M | -6.21M | 539.00K | -4.38M | -993.00K | 20.96M |
Avant Brands Technical Analysis
Negative
0.60
Price Trends
0.57
Negative
0.58
Negative
0.65
Negative
Market Momentum
-0.02
Negative
45.27
Neutral
56.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AVNT, the sentiment is Negative. The current price of 0.6 is above the 20-day moving average (MA) of 0.53, above the 50-day MA of 0.57, and below the 200-day MA of 0.65, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 45.27 is Neutral, neither overbought nor oversold. The STOCH value of 56.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AVNT.
Avant Brands Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$3.40M | -1.75 | -43.92% | ― | -18.30% | -397.37% | |
46 Neutral | C$7.61M | -0.63 | -43.60% | ― | -15.88% | 59.93% | |
45 Neutral | C$5.21M | 6.25 | -11.60% | ― | -4.90% | ― | |
43 Neutral | C$6.20M | -1.62 | -31.36% | ― | -18.09% | -248.08% |
* Healthcare Sector Average
TSE:AVNT
Avant Brands
0.50
-0.07
-13.16%
TSE:TGIF
1933 Industries
0.01
>-0.01
-33.33%
TSE:OILS
Nextleaf Solutions
0.02
-0.04
-66.67%
TSE:CLC
Christina Lake Cannabis
0.03
-0.02
-37.50%
TSE:HASH
Simply Solventless Concentrates Ltd
0.05
-0.21
-82.00%
Avant Brands Corporate Events
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
Avant Brands Returns to Profit as Recreational Cannabis Sales Surge and Flowr Retrofit Boosts Output
Positive
Oct 15, 2026
Avant Brands reported a return to profitability in its third quarter of 2026, posting net income of $0.2 million versus a loss a year earlier, as adjusted EBITDA rose to $1.3 million on a higher‑margin sales mix and tighter costs. While tota...
Business Operations and StrategyRegulatory Filings and Compliance
Avant Brands Advances EU GMP Certification Effort at Key Kelowna Cannabis Facility
Positive
Aug 20, 2026
Avant Brands Inc., a leading Canadian producer of premium indoor cannabis, has built a diversified footprint across recreational, medical, and export markets. With brands including blk mkt, Tenzo, Cognōscente, Flowr, and Treehugger, and opera...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.